Ricevi le ultime notizie sulle azioni Surrozen con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di SRZN

Ultime notizie per

Surrozen

Surrozen Inc

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adicet Bio

Alpha Cognition

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Atossa Therapeutics

Biomea Fusion

Clene

Citius Oncology

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

EXoZymes

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Immix Biopharma

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

OKYO Pharma

Oncolytics Biotech

Ovid Therapeutics

Pelthos Therapeutics

AVITA Medical

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Shattuck Labs

Instil Bio

Tevogen Bio Holdings

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Surrozen (SRZN) Previsione

Notizie

Utili

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Comments

Surrozen Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO